首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1746960

日本新生兒篩檢市場報告（按產品、技術、檢測類型和地區）2025-2033

Japan Newborn Screening Market Report by Product, Technology, Test Type, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本新生兒篩檢市場規模達6,440萬美元。展望未來， IMARC Group預計到2033年，該市場規模將達到1.075億美元，2025-2033年期間的複合年成長率（CAGR）為5.9%。醫療技術的持續創新，旨在提高疾病檢測的準確性和效率，是推動區域市場發展的主要動力。

新生兒篩檢包含一系列實驗室評估和即時檢查，旨在及早發現、診斷和干涉出生後可能不會立即顯現的遺傳、代謝、血液或荷爾蒙失調。其主要目的是及早發現可能導致嚴重發病率、死亡率和智力障礙 (ID) 的疾病，以便在症狀顯現之前及時啟動治療。典型的新生兒篩檢流程包括從嬰兒足跟採集少量血樣，進行簡單的血液檢測。隨後，對血液樣本進行檢測以評估各種狀況，包括代謝紊亂、內分泌失調以及血液相關疾病，例如苯丙酮尿症 (PKU)、囊性纖維化和鐮狀細胞性貧血。如果初步篩檢結果顯示新生兒患有遺傳性疾病，則需要進行額外的確認性檢測以確認診斷。這可以及時實施適當的治療，並制定後續護理計劃，以保障嬰兒的健康。

日本新生兒篩檢市場趨勢：

日本新生兒篩檢市場正在經歷顯著成長，這主要得益於父母（尤其是新手父母）對子女健康的日益關注。這種擔憂源於嬰兒先天性疾病的日益增多。父母越來越意識到早期發現和診斷在促進及時醫療干預和治療方面的關鍵作用，這進一步推動了市場的擴張。醫療技術和基因檢測的進步顯著拓寬了可篩檢疾病的範圍，增強了市場前景。各國政府和醫療保健機構擴大採用新生兒篩檢項目，這進一步促進了市場的積極發展。持續的產品創新，例如新一代定序和串聯質譜技術的整合，提高了篩檢的準確性和速度，進一步促進了市場的成長。直接面對消費者的基因檢測的普及以及對個人化醫療的日益關注，正在推動根據個人特定基因特徵制定個人化治療方案，從而進一步刺激市場需求。醫療保健支出增加、數位化快速發展、網際網路速度加快、線上健康社區的出現以及廣泛的研發 (R&D) 工作等因素將有助於預測期內市場的整體成長和進步。

日本新生兒篩檢市場細分：

產品洞察：

儀器
試劑

技術洞察：

串聯質譜法
脈搏血氧儀
基於酵素的測定
DNA檢測
電泳
其他

測試類型洞察：

乾血斑測試
慢性腎臟病
聽力篩檢

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本新生兒篩檢市場目前表現如何？未來幾年將如何表現？
COVID-19 對日本新生兒篩檢市場有何影響？
日本新生兒篩檢市場依產品分類是怎樣的？
日本新生兒篩檢市場依技術分類的分佈如何？
根據測試類型，日本新生兒篩檢市場是如何分類的？
日本新生兒篩檢市場的價值鏈分為哪些階段？
日本新生兒篩檢的主要促進因素和挑戰是什麼？
日本新生兒篩檢市場的結構是怎麼樣的？主要參與者是誰？
日本新生兒篩檢市場的競爭程度如何？

本報告回答的關鍵問題：

日本新生兒篩檢市場目前表現如何？未來幾年將如何表現？
COVID-19 對日本新生兒篩檢市場有何影響？
日本新生兒篩檢市場依產品分類是怎樣的？
日本新生兒篩檢市場依技術分類的分佈如何？
根據測試類型，日本新生兒篩檢市場是如何分類的？
日本新生兒篩檢市場的價值鏈分為哪些階段？
日本新生兒篩檢的主要促進因素和挑戰是什麼？
日本新生兒篩檢市場的結構是怎麼樣的？主要參與者是誰？
日本新生兒篩檢市場的競爭程度如何？

Japan newborn screening market size reached USD 64.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 107.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.9% during 2025-2033. Continuous innovations in medical technology for more accurate outcomes and efficiency of disease detection are primarily driving the regional market.

Newborn screening encompasses a series of laboratory assessments and point-of-care examinations designed for the early detection, diagnosis, and intervention of genetic, metabolic, hematological, or hormonal disorders that may not manifest immediately after birth. The primary objective is to identify diseases that have the potential to cause significant morbidity, mortality, and intellectual disability (ID) at an early stage, enabling prompt initiation of treatment before symptoms become evident. The typical newborn screening process involves the collection of a small blood sample from the baby's heel, which is subjected to a straightforward blood test. Subsequently, the blood sample undergoes testing to assess various conditions, including metabolic disorders, endocrine irregularities, and blood-related ailments such as phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. Should the initial screening results suggest a genetic disorder in the newborn, additional confirmatory testing becomes necessary to validate the diagnosis. This enables timely administration of appropriate treatment and the establishment of a follow-up care plan for the infant's well-being.

Japan Newborn Screening Market Trends:

The Japan newborn screening market is witnessing significant growth, primarily driven by heightened parental concerns for their children's health, especially among new parents. This concern is rooted in the increasing prevalence of congenital conditions in infants. Parents are becoming more aware of the critical role early detection and diagnosis play in facilitating timely medical intervention and treatment, further propelling the market's expansion. Advancements in medical technology and genetic testing have significantly broadened the range of disorders that can be screened for, enhancing the market's prospects. Governments and healthcare organizations are increasingly adopting newborn screening programs, adding to the market's positive trajectory. Ongoing product innovations, such as the integration of next-generation sequencing and tandem mass spectrometry, offer improved screening accuracy and speed, further bolstering market growth. The availability of direct-to-consumer genetic testing and a growing focus on personalized medicine are driving tailored treatments tailored to individuals' specific genetic profiles, further stimulating market demand. Factors such as increased healthcare expenditure, rapid digitization, higher internet speeds, the emergence of online health communities, and extensive research and development (R&D) efforts will contribute to the market's overall growth and advancement over the forecasted period.

Japan Newborn Screening Market Segmentation:

Product Insights:

Instruments
Reagents

Technology Insights:

Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others

Test Type Insights:

Dry Blood Spot Test
CCHD
Hearing Screen

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan newborn screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan newborn screening market?
What is the breakup of the Japan newborn screening market on the basis of product?
What is the breakup of the Japan newborn screening market on the basis of technology?
What is the breakup of the Japan newborn screening market on the basis of test type?
What are the various stages in the value chain of the Japan newborn screening market?
What are the key driving factors and challenges in the Japan newborn screening?
What is the structure of the Japan newborn screening market and who are the key players?
What is the degree of competition in the Japan newborn screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Newborn Screening Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Newborn Screening Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Newborn Screening Market - Breakup by Product

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Newborn Screening Market - Breakup by Technology

7.1 Tandem Mass Spectrometry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Pulse Oximetry
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Enzyme Based Assay
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 DNA Assay
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Electrophoresis
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Newborn Screening Market - Breakup by Test Type

8.1 Dry Blood Spot Test
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 CCHD
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Hearing Screen
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Newborn Screening Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Newborn Screening Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis